28
IRUS Total
Downloads
  Altmetric

A One-Health environmental risk assessment of contaminants of emerging concern in London’s waterways throughout the SARS-CoV-2 pandemic

File Description SizeFormat 
1-s2.0-S016041202300483X-main (1).pdfPublished version8.56 MBAdobe PDFView/Open
Title: A One-Health environmental risk assessment of contaminants of emerging concern in London’s waterways throughout the SARS-CoV-2 pandemic
Authors: Egli, M
Rapp Wright, H
Oloyede, O
Francis, W
Preston-Allen, R
Friedman, S
Woodward, G
Piel, FB
Barron, LP
Item Type: Journal Article
Abstract: The SARS-CoV-2 pandemic had huge impacts on global urban populations, activity and health, yet little is known about attendant consequences for urban river ecosystems. We detected significant changes in occurrence and risks from contaminants of emerging concern (CECs) in waterways across Greater London (UK) during the pandemic. We were able to rapidly identify and monitor large numbers of CECs in n=390 samples across 2019–2021 using novel direct-injection liquid chromatography-mass spectrometry methods for scalable targeted analysis, suspect screening and prioritisation of CEC risks. At total of 10,029 measured environmental concentrations (MECs) were obtained for 66 unique CECs. Pharmaceutical MECs decreased during lockdown in 2020 in the R. Thames (p≤0.001), but then increased significantly in 2021 (p ≤0.01). For the tributary rivers, the R. Lee, Beverley Brook, R. Wandle and R. Hogsmill were the most impacted primarily via wastewater treatment plant effluent and combined sewer overflows. For the R. Hosgmill in particular, pharmaceutical MEC trends were generally correlated with NHS prescription statistics, likely reflecting limited wastewater dilution. Suspect screening of ∼1,200 compounds tentatively identified 25 additional CECs at the five impacted sites, including metabolites such as O-desmethylvenlafaxine, an EU Watch List compound. Lastly, risk quotients (RQs) ≥0.1 were calculated for 21 compounds across the whole Greater London freshwater catchment, of which 7 were of medium risk (RQ ≥1.0) and three were in the high-risk category (RQ ≥10), including imidacloprid (RQ=19.6), azithromycin (15.7) and diclofenac (10.5). This is the largest spatiotemporal dataset of its kind for any major capital city globally and the first for Greater London, representing ∼16 % of the population of England, and delivering a foundational One Health case study in the third largest city in Europe across a global pandemic.
Issue Date: Oct-2023
Date of Acceptance: 12-Sep-2023
URI: http://hdl.handle.net/10044/1/106625
DOI: 10.1016/j.envint.2023.108210
ISSN: 0160-4120
Publisher: Elsevier
Journal / Book Title: Environment International
Volume: 180
Copyright Statement: © 2023 Published by Elsevier Ltd. This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Publication Status: Published
Article Number: 108210
Online Publication Date: 2023-09-14
Appears in Collections:Faculty of Medicine
Imperial College London COVID-19
School of Public Health



This item is licensed under a Creative Commons License Creative Commons